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INTRODUCTION AND 
JUSTIFICATION
Oesophageal surgery involves a major surgical and physiological 
insult to the body with associated significant morbidity and mortality. 
Oesophageal surgery remains a demanding surgical procedure for surgeons 
who deal with benign and malignant disease of oesophagus. Significant 
advances in perioperative and postoperative care have occurred in the past 
decade. However mortality and morbidity rates associated with 
oesophagectomy worldwide remain high. Major contributors to the mortality 
and morbidity are post operative pulmonary complications.
Pulmonary complications remain the most common complications 
that develop after oesophageal surgery1. The incidence of pulmonary 
complications has been reported to vary from 17% 2to 45%3 in published 
literature. These account for up to 50% of the hospital deaths in patients 
undergoing oesophagectomy4.
20% of patients who undergo oesophageal surgery require prolonged 
ventilatory support and undergo tracheostomy in the intensive care setting5.
The role of early tracheostomy in critically ill patients has been 
extensively studied6.  Recent literature has shown that an early tracheostomy 
in the intensive care setting, for patients requiring prolonged ventilation, 
reduces the duration of ventilation, duration of ICU stay and mortality.  The 
timing of tracheostomy is still a matter of debate, but clearly there is a 
definite trend that the earlier tracheostomy is associated with better outcome 
in terms of morbidity and mortality.
Elective tracheostomy for patients undergoing major oesophageal 
surgery has not been studied so far, though some centers have been using the 
same in a few patients. This study aims at evaluating the effect of 
tracheostomy performed at the time of primary operation, in reducing 
pulmonary complications and improving outcomes after major oesophageal 
surgery.
AIMS AND OBJECTIVES OF THE 
STUDY
To evaluate the effect of elective tracheostomy on morbidity 
and mortality following oesophageal surgery with neck 
anastomosis
 REVIEW LITERATURE
Anatomy of the Oesophagus
The oesophagus is a muscular tube that begins at the lower border of 
the cricoid cartilage (at the level of C6 vertebrae) and ends in the abdomen 
at the cardiac orifice of the stomach (at the level of T11 vertebrae). It is 25 
cm long and is divided into cervical, thoracic and abdominal parts.  The 
cervical oesophagus inclines slightly to the left of the midline and returns to 
the midline at the T5 vertebral level.  It continues down and pierces the 
diaphragm about 2.5 cm to the left of midline at the level of T10 vertebra.7
The oesophagus lacks serosa and is surrounded by a layer of loose 
fibro alveolar adventitia.  Beneath the adventitia is a layer of longitudinal 
muscle,  overlying  an  inner  layer  of  circular  muscle.  Between  the  two 
muscular layers lie the blood vessels and ganglion cells (Auerbach plexus). 
Both the longitudinal and circular muscle layer of the upper third of 
the oesophagus are striated whereas the layers of the lower third are smooth.
The oesophageal  mucosa is of squamous epithelium except for  the 
distal 1 to 2 cm, which is junctional columnar epithelium. 8
The  cervical  oesophagus  receives  blood  from the  superior  thyroid 
artery as well as the inferior thyroid artery. The major blood supply of the 
thoracic  oesophagus  is  from  four  to  six  aortic  oesophageal  arteries, 
supplemented  by collateral  vessels  from the inferior  thyroid,  intercostals, 
bronchial,  inferior  phrenic  and  left  gastric  arteries.8 They  are  slender, 
tenuous  vessels  and  this  makes  it  possible  to  mobilize  the  intrathoracic 
oesophagus by blind digital dissection from the suprasternal notch above and 
from the oesophageal hiatus below during transhiatal oesophagectomy.
 The veins of the cervical oesophagus drain into the inferior thyroid 
vein. The veins on the left side of the thoracic oesophagus drain into the 
brachiocephalic vein via the left hemiazygous system. On the right side, the 
drainage is through the azygous system into the superior vena cava. At the 
cardio oesophageal junction, venous drainage of the oesophagus may be into 
the  coronary,  splenic,  retroperitoneal  and  inferior  phrenic  veins  which 
connect with the portal and caval systems9.
Many of the complications of oesophageal surgery are directly related 
to specific features of oesophageal anatomy and physiology. One distinct 
feature of oesophageal anatomy is its unusually fatty submucosa, which 
allows greater mobility of the overlying squamous mucosa.  When 
performing an oesophageal anastomosis manually, meticulous technique is 
essential to ensure that every suture traverses the mucosal edge, which 
sometimes can retract up to 1 cm.10
OESOPHAGEAL OPERATIONS
Oesophageal operations are some of the most demanding procedures 
of the gastrointestinal tract. The postoperative morbidity and mortality rates 
remain high in spite of the advances in surgical technique and perioperative 
care.   Two  of  the  most  common  conditions  requiring  surgery  upon  the 
oesophagus  are  carcinoma  oesophagus  and  corrosive  injury  to  the 
oesophagus.
CARCINOMA OESOPHAGUS
Oesophageal carcinoma continues to be a challenge to the surgeon and 
the oncologist. The classical presentation is one of progressively worsening 
dysphagia, and the disease is usually at an advanced stage at presentation11. 
Both surgery and chemoradiation are being used as modalities of treatment11. 
However, despite numerous clinical trials, none has been proven superior to 
the other.  
Only about 50% of  patients  are  eligible  for  a curative resection at 
presentation12. In the absence of metastatic disease, an oesophagectomy can 
be performed with a gastric pull-up for reconstruction.  In cases where the 
stomach is involved by tumor, colon can be used as an alternative conduit. 
Since 1970, the reported 5-year survival rates for patients undergoing 
oesophagectomy  has  risen  from  10%-15%  to  a  high  of  35%13.  This  is 
secondary  to  refinements  in  surgical  technique,  improved  anesthesia  and 
critical  care  management  and  an  emphasis  on  nutrition  by  enteral  or 
parenteral  routes13.  Despite  these  improvements  in  surgical  outcome,  the 
overall survival rate for carcinoma oesophagus has changed little.
Oesophagectomy  can  be  performed  by  any  of  the  following 
approaches - transhiatal, transthoracic or video-assisted.  None of them has 
been shown to have any survival advantage over the other10,14.
TRANSTHORACIC OESOPHAGECTOMY
Transthoracic oesophagectomy may be performed via a left or right 
thoracoabdominal  incision,  separate  posterolateral  thoracic  incision  and 
abdominal  incision  (Ivor-Lewis  oesophagectomy)  and  cervical, 
posterolateral  thoracic  and  abdominal  incision  (Mckeown’s 
oesophagectomy). 
A transthoracic surgery allows complete resection of the tumor and 
also enables one to do a lymph node dissection under direct vision.
Disadvantages  of  transthoracic  oesophagectomy  include  increased 
post operative morbidity and mortality due to combined chest and abdominal 
incisions. Although disruption of an intrathoracic oesophageal anastomosis 
is reported less frequently than a cervical anastomotic leak from a transhiatal 
oesophagectomy, the consequences, including mediastinitis and sepsis, are 
fatal in up to 40% of patients15. The operative mortality varies significantly 
depending on the centre, ranging from 14% to 2.2%15.
TRANSHIATAL OESOPHAGECTOMY
Here the entire thoracic oesophagus is dissected through a widened 
hiatus, without performing a thoracotomy.  Reconstruction is achieved by 
tubing the stomach and pulling it to the neck, with a cervical oesophago-
gastric anastomosis.
Transhiatal  oesophagectomy  is  associated  with  a  low  operative 
mortality of 2 to 8% and an anastomotic leak rate of 5 to 19% 16,17. Orringer 
et. al. reviewed their 22 year experience with transhiatal oesophagectomy 
(1085 patients). They reported hospital mortality of 4% with an anastomotic 
leak rate of 13%18.
Transhiatal  oesophagectomy minimizes  the  operative  insult  to  the 
patient  by  avoiding  a  thoracotomy.  The  incidence  of  post  operative 
pulmonary  complications  is  thereby  reduced,  and  the  possibility  of 
mediastinitis secondary to an intrathoracic leak is virtually eliminated.
Critics of transhiatal oesophagectomy object to the limited exposure 
to the intrathoracic oesophagus. The limited exposure potentially increases 
the  risk  of  uncontrolled  haemorrhage  by injury  to  the  azygous  vein,  the 
pulmonary veins or  the aortic arch and precludes a complete  mediastinal 
lymph node dissection for purposes of staging and potential cure. 
A review of the literature with a meta-analysis, however, has shown 
that  operative  blood  loss  is  significantly  less  during  transhiatal  than 
transthoracic  oesophagectomy14.  The  overall  in-hospital  mortality  for 
transhiatal  oesophagectomy  is  5.7%  versus  9.2%  for  transthoracic 
oesophagectomy with no significant  difference in 3 and 5-year survival15. 
Contraindications include evidence of tumour invasion of the pericardium, 
aorta  or  tracheo-bronchial  tree15.  Leak  rates  are  higher  with  transhiatal 
oesophagectomy  (13.6% for  transhiatal  versus  7.2% for  transthoracic) 18. 
However, the leak is in the neck and it heals spontaneously15. 
THORASCOPIC ASSISTED OESOPHAGECTOMY
Thoracoscopic assisted oesophagectomy involves three steps: the first 
is thoracoscopic dissection of the intrathoracic oesophagus. The second is 
the  laparoscopic  mobilization  of  the  gastric  conduit  and  the  third  is  the 
cervical anastomosis. There is an operative mortality of up to 13.5%19. The 
morbidity  has  been  reported  to  be  27  to  55%20,21.  Although,  technically 
feasible, the success of thoracoscopic oesophagectomy is highly dependant 
on  the  experience  of  the  surgeon.  No  currently  available  technique  is 
considered standard. Thoracoscopic oesophagectomy has not been shown to 
reduce  the  length  of  hospitalization  or  complications  when  compared  to 
open  surgical  procedures19.  Randomized  trials  with  longer  follow up  are 
required to fully evaluate the procedure10.
CORROSIVE STRICTURE OESOPHAGUS
One  of  the  oesophageal  pathology  that  requires  major  surgical 
intervention  is  caustic  injury  to  the  oesophagus.  Initial  management  is 
usually conservative but many of these patients present at a later date with 
stricture of the esophagus and in most cases, also the stomach. The treatment 
of choice is oesophageal  dilatations in patients with single  strictures.   In 
cases of multiple strictures, long segment strictures, very tight strictures and 
failed dilatations, an operative procedure is indicated.  Gastric pull up is the 
preferred treatment if the stomach is adequate in length and not injured by 
the corrosive. However in majority of the patients with caustic injury, the 
stomach  is  also  involved  and  a  colon  bypass  is  required.  This  can  be 
achieved via  a  substernal  tunnel  or  via  the  posterior  mediastinum,  using 
side-to-side anastomosis between the cervical oesophagus and left or right 
colon10.  These patients are nutritionally depleted and are hence prone for 
post operative respiratory complications and anastomotic leak11.
COMPLICATIONS OF OESOPHAGEAL SURGERY
Oesophageal surgery is a major undertaking involving opening of 
multiple body cavities, prolonged operating time and major blood loss.  The 
patients are malnourished secondary to decreased oral intake due to 
dysphagia. Most patients give history of chronic smoking and co-existing 
lung disease. Therefore it is not unusual to find that these operations are 
associated with a high complication rate.
Pulmonary complications are the most common complications 
following oesophagectomy and are the leading cause of mortality related to 
the procedure1.  These have been discussed in detail later.
Some of the other complications of oesophagectomy include 
cardiovascular complications, anastomotic leaks and strictures, chylothorax, 
gastric outlet obstruction, and recurrent laryngeal nerve injuries.
CARDIOVASCULAR COMPLICATIONS
Arrhythmias are common after oesophagectomy and commonly occur 
on day 2-4.  These are often an early sign of pulmonary complications, 
anastomotic leak or sepsis22.
Postoperative supraventricular tachyarrhythmias are associated with 
an increased mortality 23. Early recognition and treatment is therefore 
necessary.
Treatment of the underlying cause, correction of electrolyte 
abnormality or pharmacological therapy with a cardiac glycoside is usually 
effective 22.
ANASTOMATIC LEAKS 
The  overall  incidence  of  anastomotic  leaks  after  oesophagectomy 
ranges from 12% to 30% as per several studies. This wide range shows the 
involvement  of  multiple  perioperative  factors  that  play  a  role  in  its 
development. 
Pre operative factors include 
• presence of other co morbid illnesses22 
• poor nutritional status24
• low hematocrit and24
• neoadjuvant chemotherapy24 
Intraoperative factors include 
• experience of the surgeon25
• conduit ischaemia24
• cervical anastomosis26 
• estimated blood loss26
• anastomosis being performed via a retrosternal or subcutaneous 
route as opposed to an intrathoracic route27 
• use of colonic interposition as opposed to gastric pedicle27 
• performing a manual anastomosis as opposed to a mechanical 
anastomosis27 
• employing an end to end anastomosis as opposed to an end to 
side anastomosis using a mechanical technique27
Although  management  of  cervical  anastomotic  leak  is  usually 
conservative, the long term sequelae of a cervical leak are significant. Upto 
50%  of  cervicoesophagogastric  anastomotic  leaks  result  in  anastomotic 
stricture, as healing occurs. This represents an unsatisfactory outcome of an 
operation that is intended to provide comfortable swallowing. These can be 
managed with endoscopic pneumatic dilatations and may require multiple 
sessions of the same.
CHYLOTHORAX
The thoracic duct travels alongside the oesophagus and crosses over to 
the left at the fifth thoracic vertebrae level. It can be injured at any point in 
its entire course, leading to a chylothorax.
This is identified by leakage of chyle from the intercostal tube.  If 
there is no intercostal tube in situ, chylothorax presents with massive pleural 
effusion leading on to respiratory embarrassment22.
Initial conservative management is applied.  However in patients with 
high output, and those not responding to conservative management, surgical 
ligation is indicated22.
GASTRIC OUTLET OBSTRUCTION
Recurrent  vomiting  and  aspiration  after  oesophagectomy,  most 
commonly is due to gastric outlet obstruction.  Absence of a pyloroplasty or 
an inadequate pyloroplasty is the usual cause.
Contrast  radiology  establishes  the  diagnosis.   Initially  balloon 
dilatation may be tried, however most patients require a re-operation22.
RECURRENT LARYNGEAL NERVE INJURY
Recurrent laryngeal nerve injury during oesophagectomy may result 
in one of the most devastating complications, cricopharyngeal muscle 
dysfunction, with resultant incapacitating cervical dysphagia10.  
TRACHEO OESOPHAGEAL FISTULA
One of the most disastrous complications after oesophageal resection 
and reconstruction is the development of a fistulous communication between 
the tracheobronchial tree and either the oesophagus or the oesophageal 
substitute, generally at the site of anastomosis.  Once a fistula develops there 
is little option other than to prevent repeated contamination of the 
tracheobronchial tree by identifying and dividing the fistula and repairing 
the airway10,22. This is a major undertaking in a desperately ill patient.
Other complications include stridor and hoarseness of voice.  Speech 
retraining with the help of a speech therapist helps in such conditions 22.
POST OPERATIVE PULMONARY PHYSIOLOGY
A host of factors contribute to the abnormal pulmonary physiology 
after an operative procedure. 
A loss of functional residual capacity is present in virtually all 
patients11. This loss may be due to 
• abdominal distention
• painful upper abdominal incision
• obesity 
• strong smoking history with associated chronic obstructive 
pulmonary disease
• prolonged supine positioning
• fluid overload leading to pulmonary edema
Virtually all patients who undergo an abdominal incision or a thoracic 
incision have a significant alteration of their breathing pattern. Vital capacity 
may be reduced up to 50% of normal for the first 2 days after surgery for 
reasons that are not completely clear11. 
Use of narcotics substantially inhibits the respiratory drive, and the 
effect of anesthetics may take some time to wear off11.
After a thoracotomy, the reduced lung volumes and spirometry may 
take up to 6 months to come back to normal28.
A host of iatrogenic maneuvers place the patient at increased risk for 
aspiration pneumonitis.  During anesthesia induction, patients are sedated 
and lose control of the ability to clear the airway. The aforementioned 
setting is probably the most common cause of aspiration11. The patient with 
a nasogastric tube is also at a high risk for aspiration pneumonia.
The sensitivity and force of the cough reflex is decreased during the 
post operative period. This can be attributed to the paresis or damage of the 
vagus nerve during dissection or due to diaphragmatic injury during 
dissection.  This leads to increased risk of aspiration pneumonia2.
Major surgery is associated with an elevation of inflammatory 
mediators within the lungs, with a concomitant increase in vascular 
permeability and fluid sequestration29.  Thoracotomy exacerbates these 
effects, and single lung ventilation adds further to the insult22. These can lead 
to acute lung injury and ARDS.
Meticulous attention to fluid replacement and maintenance during 
surgery and during the post operative period is required with particular 
attention to prevent fluid overload.  Fluid overload both intraoperatively and 
post operatively, is the major cause of post operative pulmonary oedema11.
SINGLE LUNG VENTILATION
Single lung ventilation is frequently used in oesophageal surgery to 
improve surgical access to the oesophagus. This is most commonly achieved 
with a Robertshaw double lumen endotracheal tube. Right and left sided 
tubes are available in different sizes.
Single lung ventilation causes major physiological changes and can 
cause injury to both the dependent and non dependent lung. The principal 
physiologic change of OLV is the redistribution of lung perfusion between 
the ventilated (dependent) and blocked (nondependent) lung30. Many factors 
contribute to the lung perfusion; the major determinants of them are hypoxic 
pulmonary vasoconstriction (HPV) and gravity30. 
HPV, a local response of pulmonary artery smooth muscle, decreases 
blood flow to the area of lung where a low alveolar oxygen pressure is 
sensed. It aids in keeping a normal V/Q relationship by diversion of blood 
from under ventilated areas, responsible for the most lung perfusion 
redistribution in OLV. The mechanism of HPV is not completely 
understood.
PULMONARY COMPLICATIONS
In every series of patients undergoing oesophageal resection and 
substitution with stomach or colon, the leading causes of death is respiratory 
insufficiency1. 
The incidence of pulmonary complications after oesophagectomy has 
been reported as varying from 17% to 45%.2,3,5
These account for up to 50% of the hospital deaths in these patients4. 
20% of these patients require prolonged ventilatory support31.
The common pulmonary complications include aspiration pneumonia, 
acute lung injury and ARDS, pleural effusion, pneumothorax and 
chylothorax.
Aspiration Pneumonia is the most common pulmonary complication 
and is seen in up to 32% of the patients1.  It is defined as the presence of new 
pulmonary infiltrates on chest radiograph associated with fever, raised white 
cell count or necessitating antibiotic use 1.
Acute Lung Injury (ALI) is a distinct form of acute respiratory failure 
characterized by diffuse pulmonary infiltrates, progressive hypoxemia, 
reduced lung compliance and normal hydrostatic pressures3. ARDS or Adult 
Respiratory Distress Syndrome is a more severe form of ALI.  These are 
diagnosed when all the following are present (American European 
Consensus Conference definition) 32
• Bilateral pulmonary infiltrates on chest x-ray
• Pulmonary Capillary Wedge Pressure <18mmHg
•  PaO2/FiO2 <300 = ALI
•  PaO2/FiO2 <200 = ARDS
Pleural effusion is common after oesophagectomy and may 
necessitate intercostal tube drainage.
Pneumothorax occurring after oesophagectomy may also lead to 
intercostal tube insertion, thus contributing to operative morbidity.
PREDICTORS OF PULMONARY COMPLICATIONS
A large number of studies have been done on pre operative prediction of 
pulmonary complications in patients undergoing oesophagectomy. In spite 
of the large volume of literature being available on the subject, no specific 
criteria exist to classify patients into specific risk groups.  Most centers 
continue to use their own criteria to choose patients suitable for 
oesophagectomy, based on experiences at their own centre. 
Some of the risk factors associated with the development of pulmonary 
complications include age, history of smoking, poor pre operative 
spirometry, duration of surgery, blood loss during surgery, duration of one 
lung ventilation, and concurrent liver disease.
Advanced age has been identified as a risk factor for both pulmonary 
complications and death after oesophagectomy1,5,33,34,35. The chance of 
developing pulmonary complications was twice in patients older than 
seventy years and the mortality was four fold33.  The adverse factors 
responsible for adverse outcome in elderly patients seem to be the presence 
of preexisting cardiopulmonary illness.
Smoking has also been identified as a major risk factor for development 
of post operative pulmonary complications3.  These patients have an 
underlying chronic obstructive lung disease and are hence more prone to 
complications.  Total abstinence from smoking for as short a period as 3 
weeks can lead to an improvement in outcome in such patients.
Poor pre operative spirometry is also a predictor of poor post operative 
outcome1,5,34,36,37. The FEV1 (forced expiratory volume in one second) when 
compared to the expected (as a percentage) is a good indicator of risk. 
Patients with FEV1 less than 65% of the predicted have a higher 
complication rate and higher mortality1,5,34,36,37.
The forced vital capacity is also a good indicator to predict post operative 
pulmonary complications and mortality.  A FVC of less than 90% of 
expected leads to more complications and morbidity5,36.
Longer operation duration3,33 and more intraoperative blood loss4,35 were 
associated with more pulmonary complications and more hospital deaths. 
Both factors may be associated with more advanced tumors, where tumor 
resection was more difficult.  Decreased blood loss and blood transfusion 
have been shown in other studies to correlate with decreased hospital death 
rate as well as with long term survival after major cancer surgery.
Duration of single lung ventilation is also a factor in post operative 
pulmonary outcome3.  To optimize surgical access the lung on the 
thoracotomy side is collapsed and all ventilation delivered to the contra 
lateral lung.  This results in injury to both the collapsed and the ventilated 
lung.  Relatively high tidal volumes are used during one lung ventilation, 
and this can induce microbarotrauma, leading to an ARDS like picture3.
Injury to the collapsed lung may be followed by reperfusion injury, 
which may add to the damage.
Single lung ventilation should thus be kept for the minimal amount of 
time to prevent pulmonary complications.
Patients with oesophageal squamous cell cancer, particularly those 
treated with preoperative chemo radiation have greater risk for post 
operative pulmonary morbidity, including pleural effusion, pneumonia and 
respiratory insufficiency38.
Intraoperative hypoxia and hypotension3, the need for ionotropic 
supports3 and presence of concurrent liver disease36,37 has also been 
associated with higher pulmonary complications.
SCORING SYSTEMS TO ASSESS RISK OF 
COMPLICATIONS
A Large number of studies have been done to predict operative risk in 
patients undergoing oesophagectomy. Few scoring systems have been 
developed for the same. However these have not gained wide acceptance 
and most centers continue to use self made criteria for choosing appropriate 
patients.
In a study at the Royal Adelaide Hospital, Australia by Liu JF, 
Watson DI and Mathew G et al., hypertension, a history of previous cigarette 
smoking and FEV1/FVC were identified as independent predictors of the 
post-operative outcome. Based on these a scoring system was developed 
which stratified patients into low, moderate and high risk for surgery39.
A study done in Germany identified a compromised general status (P 
< 0.001) and poor cardiac (P < 0.001), hepatic (P < 0.05) and respiratory (P 
< 0.05) function as independent predictors of a fatal postoperative course. 
Based on the relative risk associated with the individual impaired organ 
functions, a composite risk score was established. A prospective study in 
121 patients confirmed that this composite scoring system provides a better 
identification of high-risk patients than any of the individual parameters40.
STRATIGIES TO REDUCE PULMONARY COMPLICATIONS
A thorough knowledge of the post operative pulmonary complications 
and their predictors is essential to develop a strategy for their prevention. A 
large number of techniques, both pre, intra and post operative have been 
used to decrease pulmonary complications.
Stringent patient selection remains the cornerstone to prevent adverse 
outcome. Patients at high risk for developing complications should be 
optimized before surgery or offered other modalities of treatment.
A vital part of minimizing post operative pulmonary complications is 
vigorous preoperative pulmonary physiotherapy10. Home use of incentive 
Spiro meter and deep breathing exercises are begun at least 3 weeks 
preoperatively10. This investment of time and energy in improving the 
patient’s preoperative respiratory status is repeatedly rewarded by a lower 
incidence of pulmonary complications
Total abstinence from cigarette smoking for at least 3 weeks prior to 
surgery has been shown to improve outcome11.
A transhiatal oesophagectomy without thoracotomy and a cervical 
oesophageal anastomosis is applicable in most patients requiring 
oesophageal reconstruction for both benign and malignant disease.  This 
procedure minimizes the operative insult to the patient by avoiding a 
thoracotomy. The incidence of post operative pulmonary complications is 
thereby reduced14,15.
Adequate post operative analgesia has been associated with a lower 
cardiopulmonary complication rate and a lower mortality41. Pain aggravates 
pulmonary complications because it discourages the patient from taking 
deep inspirations, coughing effectively and cooperating with the chest 
physiotherapist.
Routine use of a thoracic epidural catheter for analgesia has 
contributed to significant decrease in morbidity and mortality due to 
respiratory complications after oesophagectomy. In a study done at Queen 
Mary Hospital, Hong Kong, the incidence of post operative major 
pulmonary complications decreased from 14% to 6 % after the routine use of 
a thoracic epidural catheter for pain relief42. This difference is even more 
significant in patients requiring thoracotomy.
Routine use of fibreoptic bronchoscopy and suctioning for removal of 
mucous plugs is being used is some intensive care units in an effort to 
reduce pulmonary complications22.
Various other methods such as nebulisations, use of steam inhalation 
and mucolytics have also been used in an effort to reduce pulmonary 
complications.
TRACHEOSTOMY IN THE INTENSIVE CARE UNIT
Tracheostomy is a surgically created opening in the neck which 
allows direct access to the trachea, and through which a tracheostomy tube is 
placed for respiration. Since its first description by Chevalier Jackson in 
1909, it has been widely used in modern medicine. It is one of the most 
commonly performed procedures in the critically ill patients
Open surgical tracheostomy has been practiced for a long time in 
modern medicine. Sheldon and colleagues first described the method of 
percutaneous tracheostomy in 1969. However the classic method of 
percutaneous dilatational tracheostomy was described by Ciaglia and 
colleagues in 198543.
There has been considerable debate in recent literature about the role 
of a tracheostomy in patients admitted to an intensive care unit. A few 
salient points are highlighted below.
ADVANTAGES 
A tracheostomy gives practical and theoretical advantages 
compared with conventional orotracheal intubation in ventilated patients. 
• It provides a more secure airway
• It avoids laryngeal and vocal cord trauma
• It reduces airway resistance and dead space, thereby 
reducing the work of breathing
• It allows for easier nursing care
• Oral feeding is possible with a tracheostomy in place.
• It improves patient comfort and is better tolerated than an 
orotracheal tube.
• Better pulmonary hygiene is possible.
COMPLICATIONS OF TRACHEOSTOMY
Although there are clear advantages of a tracheostomy over 
orotracheal intubation, a tracheostomy is not without its complications.
The complications associated with a tracheostomy can be classified as 
immediate, early and late.
IMMEDIATE COMPLICATIONS
These usually occur at the time of the procedure
• Apnea – this usually occurs in people with chronic 
airway obstruction
• Bleeding – this usually is from the skin and subcutaneous 
tissue and stops on its own.
• Pneumothorax
• Pneumomediastinum 
• Injury to adjacent structures 
EARLY COMPLICATIONS
These occur during the first week of tracheostomy
• Bleeding 
• Mucus obstruction
• Inflammation of the trachea 
• Tube displacement 
• Subcutaneous emphysema 
• Pulmonary infection
LATE COMPLICATIONS
These occur after 1 week of the tracheostomy
• Bleeding 
• Tracheomalacia  - usually due to degeneration of the 
elastic and connective tissue of the trachea 
• Tracheoesophageal fistula
• Tracheocutaneous fistula  
• Granulation and scarring 
• Subglottic stenosis
PERCUTANEOUS VERSUS OPEN TRACHEOSTOMY
Percutaneous dilatational tracheostomy (PDT) is increasingly being 
used in intensive care units as the procedure of choice for tracheostomy. 
However, proof of PCT's superiority to standard tracheostomy is 
contestable. Investigators who endorse PCT as the preferred technique of 
airway access maintain that PCT is cost-effective, safe, fast, and easy to 
perform44. However, certain PCT steps, such as endotracheal (ET) tube 
replacement and blind formation of tracheal stoma, can cause serious 
perioperative complications45. In addition, numerous investigators have 
proposed a learning curve for PCT46, and increased complications result for 
patients who are treated by a surgeon who is inexperienced with the 
procedure or at an institution where the procedure is preformed infrequently.
Open tracheostomy, on the other hand is a well established procedure 
and can be performed bedside or in the operating room. 
Currently both open and percutaneous tracheostomy are being used in 
most centers.  The superiority of one over the other has not been proved, and 
further prospective studies with long term follow up are required to establish 
the same. 
TIMING OF TRACHEOSTOMY
The ideal timing of a tracheostomy in critically ill patients has always 
been a debate, and evidence to guide practice has been limited. In 1989 the 
National Association of Medical Directors of Respiratory Care 
recommended that translaryngeal (endotracheal) intubation be used only for 
patients requiring less than 10 days of artificial ventilation and that a 
tracheostomy should be placed in patients who still require artificial 
ventilation 21 days after admission. 
However In 2001 they revised their guidelines and recommended that 
a tracheostomy be considered after an initial period of stabilization on the 
ventilator, when it becomes apparent that a patient will require prolonged 
ventilation.
Although these recommendations were based only on expert opinion, 
modern practice broadly seems to follow them.
Recent evidence indicates that a tracheostomy performed early (ie, 
within 3 days of intubation) may decrease the risk for pneumonia, the length 
of mechanical ventilation, and the length of stay in the ICU47,48,49.
In a study by Lesnik et.al it was shown that tracheostomy during the 
first 4 days in polytrauma patients resulted in shorter duration of ventilation. 
The mean duration of ventilation in the tracheostomy group was 6 days 
when compared to 20.6 days in the no tracheostomy group. There was also 
reduction ion duration of ICU stay in these patients50.
In a prospective randomized trial by Rodriguez et.al, polytrauma 
patients were randomized to early vs. late tracheostomy. Patients who fell in 
the early tracheostomy group (within 7 days of admission to ICU) had lesser 
days on a ventilator than the controls (12 days vs. 37 days). Also the 
duration of ICU stay was significantly shorter in these patients when 
compared to the controls51.
A meta-analysis of studies on the timing of tracheostomy in adult 
patients undergoing artificial ventilation concluded that performing a 
tracheostomy at an earlier stage than is currently practiced may shorten the 
duration of artificial ventilation and length of stay in intensive care52.
They found that an early tracheostomy 
• did not significantly alter mortality (relative risk 
0.79, 95% confidence interval 0.45 to 1.39). 
• The risk of pneumonia was also unaltered by the 
timing of tracheostomy (0.90, 0.66 to 1.21). 
• Early tracheostomy significantly reduced duration of 
artificial ventilation (weighted mean difference − 8.5 days, 95% 
confidence interval − 15.3 to  1.7), and 
• length of stay in intensive care ( − 15.3 days, − 24.6 to − 
6.1)
•
From this Meta analysis published in BMJ in 2005 it was also concluded that the 
timing of tracheostomy did not alter mortality (Relative risk 0.70, 95 % confidence 
interval 0.45-1.39, and P value 0.42)52.
However in a study by Rumbac et al. mortality was 50 % lower in the early 
tracheostomy group when compared to the late tracheostomy group.  In this study the 
tracheostomy was done within 48 hours of ICU admission53.
Early tracheostomy has not been shown to affect the risk of developing hospital 
associated pneumonias53.
From the above it is evident that an early tracheostomy is beneficial in critically 
ill patients.  How early this should be done is a matter of debate.  However, the trend is 
that the earlier the tracheostomy is done, the more are its benefits. Most studies have 
defined an early tracheostomy as one done within 7 days of translaryngeal intubation. 
However no test or scoring system is available that predicts the need for prolonged 
ventilation and hence the decision of tracheostomy is always subjective and clinical
EARLY TRACHEOSTOMY IN OESOPHAGEAL SURGERY
Currently there is no literature available on the role of an early tracheostomy in 
patients undergoing oesophageal surgery.
METHODOLOGY
This study aimed at assessing the role of an elective tracheostomy in 
reduction of mortality and morbidity due to pulmonary complications in 
patients undergoing oesophageal surgery with neck anastomosis.
DESIGN OF STUDY
Case control study with a prospective cohort of cases and a 
retrospective cohort of controls.
SELECTION CRITERIA
Patients for the study were selected according to a set of inclusion and 
exclusion criteria. They were as follows:
Inclusion criteria:
All patients undergoing oesophageal resection or bypass with a 
cervical oesophageal anastomosis.i.e.
• Substernal Colon Bypass for corrosive stricture 
oesophagus
• Mc Keowns oesophagectomy for benign or malignant 
oesophageal lesions
• Transhiatal oesophagectomy for oesophageal 
malignancies or benign oesophageal disease.
Exclusion criteria:
• Patients undergoing laryngectomy.
• Non consenting patients.
• Patients found inoperable at surgery
DURATION OF THE STUDY
The study extended from May 2005 to April 2007 (2 years)
A retrospective cohort of controls was used. Controls were chosen 
using the same inclusion criteria over a period of May 2002 to April 2005 (3 
years)
METHODOLOGY
A review of all patients who confirmed to the inclusion criteria was 
done for the year 2004.  The incidence of pulmonary complications among 
these patients was found to be 65%.  30% of these patients required 
prolonged ventilation and hence a tracheostomy. Aspiration pneumonia was 
the most common pulmonary complication (73 %) and was responsible for 
50 % of the hospital deaths.
Based on this data, the sample size was calculated to be 22.
Sample size = 4pq/d^2
Where 
p = incidence of pulmonary complications (65%)
q = 1-p (35%)
d = expected difference in outcome (=20%)
After the detailed research plan was laid down, approval was obtained 
from the Department of Upper Gastrointestinal Surgery unit and the fluid 
research committee.
All patients fitting into the inclusion criteria were included in the 
study.  Informed consent was taken prior to inclusion in the study. 
(Appendix 2)
All the include patients underwent an elective open surgical 
tracheostomy at the end of surgery. They were then transferred to the 
surgical intensive care unit for further monitoring and ventilation if required. 
No changes were made in the surgical intensive care protocols for 
monitoring these patients.
METHOD OF TRACHEOSTOMY
All the patients included in the study underwent an open surgical 
tracheostomy.  This was towards the end of surgery.
The tracheostomy was performed more lateral rather than midline in 
order to keep normal muscle interposition between the anastomotic site and 
the tracheostomy.
A portex tube (size 7 or 8) was used, which was anchored in place 
with 2-0 ethilon sutures.
After the patients were transferred to the ward from the intensive care 
unit, the portex tracheostomy tube was changed to a metal tracheostomy 
tube.
A routine nasopharyngolaryngoscopy and lateral X Ray neck were 
performed prior to decanulation. The tracheostomy was corked for 24 hours 
prior to decanulation. 
DATA COLLECTION
Data from these patients were recorded in the pre designed proforma. 
(Appendix 1) These patients were followed up till discharge from the 
hospital.  The time taken for decanulation of the tracheostomy was noted. In 
cases where the patient was discharged before decanulation, they were 
followed up on an outpatient basis till decanulation.
Data from the controls were collected in the same proforma using 
both inpatient and outpatient hospital records.
DATA ANALYSIS
                Data obtained from the study was tabulated and analyzed 
with the help of the Department of Community Medicine and Biostatistics 
and the results are presented in the next section.
DESCRIPTIVE STASTATICS
Number of cases enrolled
There  were  a  total  of  56  patients  enrolled  for  the  study.  These 
included  14  cases  and  42  controls.  This  included  patients  undergoing 
transhiatal or transthoracic oesphagectomy and substernal colon pullthrough. 
Patients who had undergone similar operations during the last 3 years were 
included in the control group.
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Fig. 1 Age distribution of patients
The distribution of study cases and controls within the different age 
groups is shown in the chart above.
The cases ranged from 17 to 61 years with a mean of 35.9 years. The 
controls varied from 19 to 75 years of age with a mean of 47.5 years. 
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Fig. 2 Sex distribution of patients
The sex distribution among study cases and controls is depicted in the 
diagram above. There were 6 males and 8 females in the case group and 29 
males and 13 females in the control group.
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Fig. 3 Diagnosis
Among the cases there were 6 cases of stricture oesophagus secondary 
to corrosive ingestion and 8 cases of carcinoma oesophagus.   Among the 
controls there were 10 cases of Corrosive stricture oesophagus and 32 cases 
of carcinoma oesophagus. This is depicted in the diagram above.
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Fig. 4 Age distribution by diagnosis
From the above chart we can see that patients with corrosive induced 
stricture of the oesophagus were much younger than those with malignant 
disease.
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Fig 5 Sex distribution by diagnosis
From the above graph we can see that there were more males with 
oesophageal carcinoma and more females with corrosive induced stricture of 
the oesophagus.
Weight 
The mean weight among the cases was 44.21 kg (range 33-64 kg), and 
that among the controls was 50.26 kgs. (Range 30-74 kg). 
Laboratory parameters
The  haemoglobin,  albumin,  FEV1  (forced  expiratory  volume  in  1 
second) and FVC (forced vital capacity) among the cases and controls were 
studied.
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Fig. 6 Mean Haemoglobin.
Mean haemoglobin among the cases was 11.7gm %( range 8.8 to 13.6 
gm %) and among controls was 11.8 gm %.( range 7.6 to 16.1 gm %)
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Fig. 7 Mean albumin
Mean albumin among cases was 3.83 gms. (Range 3.1 to 4.6 gms) and 
among controls was 3.87 (range 2.7 to 4.7 gms.)
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0
10
20
30
40
50
60
%
<90% >90%
FVC
Cases Controls
Fig. 9 FVC among cases and controls
Among the cases the FEV1 ranged from 71 % of expected to 110 % of 
expected. 3 were less than 80% of expected out of the 14 patients. The FVC 
ranged from 71.7 to 112.8 % of expected. 4 were less than 90 % of expected.
Among the controls the FEV1 ranged from 45.3 to 124 % of expected. 
6 were less than 80% of expected. The FVC ranged from 53.6 to 122.2 % of 
expected and 10 were less than 90% of expected.
OPERATIVE DETAILS
Type of surgery
Patients underwent the following surgeries
Transhiatal oesophagectomy
Transthoracic oesophagectomy
Thorascopic assisted oesophagectomy
Substernal colon bypass.
The no. of patients in each group is depicted below.
Cases Controls
Transhiatal 4 21
Transthoracic 4 10
Thorascopic Assisted 2 1
Substernal Bypass 4 10
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Fig. 10 Distribution of surgery among cases
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Fig. 11 Distribution of surgery among controls
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Fig. 12 Duration of surgery
The average duration of surgery among cases was 381 minutes with a 
range of 300 mins to 480 mins. The average blood loss was 677 ml with a 
range of 300 to 2000 ml.
Among controls the average duration of surgery was 404 minutes with 
a range of 330 to 435 minutes. The average blood loss was 978 ml with a 
range of 300 to 4000 ml.
POST OPERATIVE DETAILS
DURATION OF VENTILATION
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Fig. 13 Duration of ventilation
The  duration  of  ventilation  among  the  study  cases  and controls  is 
depicted above. From this graph we can observe that among the cases there 
were a higher proportion of patients who needed ventilation for less than 24 
hours,  where  as  among  the  controls  there  were  a  higher  proportion  of 
patients who needed ventilation for 2-3 days.
 The average duration of ventilation among cases was 4.28 days and 
among  controls  was  5.05  days.  The  median  was  2  days  for  cases  and 
controls.
Thus there was an observed difference of about 0.8 days of ventilation 
among the cases and controls. However on stastical analysis using the Mann 
Whitney test this was not found to be stastically significant. (p=0.354)
DURATION OF ICU STAY
The duration of ICU stay among cases and controls is shown in 
the graph below.
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Fig. 14 Duration of ICU stay
From this chart we can make out that among the cases there was a 
lesser number of patients requiring ICU stay for more than 6 days.
The average duration of ICU stay among cases was 6.14 days and 
among controls was 6.69 days. 
Thus there was a difference of 0.5 days of ICU stay among the cases 
and controls.  This difference was not found to be significant on stastical 
testing using the Mann Whitney test. (p=0.474)
POST OPERATIVE HOSPITAL STAY
The post operative hospital stay of the patients is depicted in the graph 
below.
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Fig. 15 Duration of Hospital stay
The mean hospital stay for cases was 19.86 (range 13 to 29 days) days 
and for controls was 19.23 days. (Range 3 to 75 days). 
However by looking at the chart above we can see that there were no 
cases that stayed in the hospital for more than 30 days where as about 10 % 
of the controls had a hospital stay of more than 30 days.
PULMONARY COMPLICATIONS
The  following  graph  depicts  the  incidence  of  pulmonary 
complications in the case and control arms.
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Fig. 16 Pulmonary complications
43 % of the cases had pulmonary complications when compared to 55 
% of the controls.
From this we can see that there were a greater proportion of controls 
cases  who  had  pulmonary  complications.  Also  we  see  that  there  was  a 
decrease in ARDS in the case group when compared to the control arm.
This  difference  also  was  however,  not  stastically  significant  on 
analysis.
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Fig. 17 ARDS in cases and controls
From the graph above we can see that the incidence of ARDS among 
the cases was considerably less than the controls. This observed difference, 
however was not stastically  significant  (p=0.26), though there is a strong 
trend towards decrease incidence of ARDS.
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Fig. 18 Death among cases and controls
Among the cases there was 1 death (7.14%) and among the controls there 
were 7 deaths (16.66 %)
The cause of death among the cases and controls is depicted in the 
table below.
Cases Controls
ARDS 1 5
Aspiration Pneumonia 0 2
This  observed difference  of  about  9  % seen in  the death rate  was 
analyzed using the Chi  Square test.  This  difference  was not  found to be 
significant. (p=0.382)
TRACHEOSTOMY
All cases underwent an elective tracheostomy.
Among  the  controls  8  patients  (19%)  required  an  emergency 
tracheostomy. The indication of this was prolonged ventilatory support due 
to ARDS or aspiration pneumonia.
Among these 8 patients, there were 4 deaths (50%).
During the course of the study there were no complications noted due 
to the tracheostomy.
Decanulation
All patients were changed to a metal tracheostomy tube in the ward 
and then subsequently decanulated.
The average time for change to a metal tube was 7 days (range 6-14 
days).
Mean time to decanulation was 14 days (range 10 – 21 days).  All 
patients were successfully decanulated. 
DISCUSSION
Pulmonary complications are the most common complications that 
develop after oesophageal surgery, and are the major cause of morbidity and 
mortality.
Various methods have been tried to reduce pulmonary complications.
A rigid patient selection criterion with inclusion of patients with good 
performance status only, has long been used.  Various scoring systems have 
also been used extensively to identify patients at a higher risk of 
complications.
In this study we used an elective tracheostomy as a tool to reduce 
pulmonary complications and mortality. These patients were compared to a 
retrospective cohort of patients who underwent a similar procedure without 
tracheostomy, over the last 3 years.
The end points used to compare outcomes were 
• Duration of ventilation
• Duration of ICU stay
• Duration of post operative hospital stay
• Development of pulmonary complications
• Death
• Complications due to tracheostomy per se
It was found that the duration of ventilation was 0.8 days less in patients 
on a tracheostomy than those without.  Though this difference was not 
stastically significant, on close observation of the data we notice that there is 
a trend that patients who had tracheostomy spent less time on a ventilator 
than those without.
Duration of ICU stay was also found to be about 0.5 days shorter in those 
with tracheostomy than those without. Although this was also not 
statistically significant, again there was a strong trend that patients with a 
tracheostomy spent less time in the ICU than those without.
Duration of post operative stay was found to be equal in both the groups. 
However on close analysis, we notice that in the tracheostomy group no 
patient spent more than 30 days in hospital, where as in the non 
tracheostomy group, a significant number of patients had a hospital stay of 
more than 30 days. 
The significance of these findings cannot be commented on this study 
due to the small sample size; however a larger study may answer this 
question.
The development of pulmonary complications was less in the 
tracheostomy group when compared to the control.  This translates into 
lesser morbidity and mortality.
Death rate in the tracheostomy group was 50 % of that of the non 
tracheostomy group. Although this was also statistically not significant, this 
trend needs to be kept in mind. A larger study is needed to conclusively 
assess the effect of tracheostomy on morbidity and mortality in patients 
undergoing oesophageal surgery.
No complications were noted in this study secondary to the 
tracheostomy.
All patients were successfully decanulated after change to a metal 
tube.
LIMITATIONS
The major limitation of this study was its sample size. 
As this study was limited to 2 years, the sample size attained was very 
small.
A larger sample size would have given a better picture of the true impact 
of tracheostomy on pulmonary complications.
Also, the controls that were used were retrospective, and hence could not 
be matched to the cases for many confounding factors. 
As the factors which affect outcome in oesophageal surgery are 
numerous, randomization would have been ideal for this study.
CONCLUSION
Prevention of pulmonary complications is the cornerstone to reduction 
of morbidity and mortality in oesophageal surgery.
This study reveals that if tracheostomy is done at the time of primary 
operation, there is a trend that the patients are weaned off the ventilator 
earlier and a shorter ICU stay. Also there is a trend that these patients are 
discharged earlier from hospital.
Although these differences did not reach stastical significance, there 
was a definite trend in the reduction of morbidity and mortality. This has 
clinical implications, especially with regard to ARDS and aspiration 
pneumonia. The small sample size and the absence of randomization in this 
study need to be kept in mind.
It has also been shown that a tracheostomy by itself is associated with 
minimal morbidity and is tolerated well by the patient.
With the above findings in mind, there is a strong case for a 
prospective randomized case control trial for evaluating elective 
tracheostomy as a strategy to reduce morbidity and mortality in patients 
undergoing oesophageal surgery.
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APPENDIX 1
CARCINOMA OESOPHAGUS STUDY PROFORMA
Name : Hospital number :
Age : Sex:       Male / Female
Address:
Date of admission :
Date of discharge :
No. of hospital days:
HISTORY
Dysphagia yes / no    duration __________         solids / liquids / both
Weight loss yes / no ________ kg.
Loss of Appetite yes / no
Cough while eating yes / no
Voice change yes / no
Back pain yes / no
Smoking yes / no ________ pack years
Alcoholism yes / no ________ years
Tobacco yes / no ________ years
Diabetes yes / no
Hypertension yes / no
IHD yes / no
COPD / asthma yes / no
Any other significant history :
EXAMINATON
Height ______ cm
Weight ______ kg.
Lymph node enlargement  : none / left or right supraclavicular / cervical
Abdominal findings  : _________
Digital Rectal Examination : _________
Other Significant findings :
INVESTIGATIONS
Hb / PCV :
TC :
DC :
Creatnine :
LFT :
PT :
APTT :
CXR : normal / abnormal  _______________________
PFT : FVC 
 FEV1
PEFR
DLCO
Final Impression
ABG :
ECG Normal / Abnormal _________________
ECHO Normal / Abnormal _________________
EF : 
TMT :
Upper GI Endoscopy : UES : 
Tumour Location :
Lumen occluded : third / two third / circumferential
Ulcerative / proliferative / infiltrative / Polypoidal
Negotiable / Non negotiable
GE Junction at :
Associated lesions :
Endoscopic biopsy : well / moderately / poorly    differentiated  
  adeno / squamous cell        carcinoma
Bronchoscopy : Not Done / Normal / Abnormal  _____________________
Bronchial washings : Positive / negative
Barium Swallow :
USG abdomen : Normal / Abnormal  _____________________
CT scan Thorax / Abdomen : 
PRE OPERATIVE CHEMO / RADIOTHERAPY
Pre Operative Chemotherapy : Yes / No
No. Of Cycles _____
Drugs Used : 
Pre Operative Radiotherapy : Yes / No
______ Gray
From ___________ to _____________
OPERATIVE DETAILS
Date of Surgery :
Type of Surgery : Ivor Lewis / Mc Keowns / Transhiatal / others
Duration Of Surgery :
Blood Loss : 
Total Fluid transfused :Colloid :
 Crystalloid :
 Blood :
Use Of Double lumen tube : Yes / No
Duration of one lung ventilation :
Use Of Epidural : Yes / No
:Level Of Epidural :
Intraoperative Hypotension : Yes / No         Duration : ________
Intraoperative Hypoxia : Yes /No    Duration : ________
Need for Ionotropic support : Yes / No ____________________
Surgical Findings :
Replacement Organ : stomach / colon / small bowel
Route : Posterior Mediastinum / Substernal / Subcutaneous
Anastomosis Level : Neck / Chest
Anastomosis Done with _______________________ using _______ Layers.
Elective Tacheostomy : Yes / No.
ICU STAY
Duration Of Ventilation :
Duration of ICU stay :
Reintubation : Yes / No
: Cause _______
Readmission to ICU : Yes / NO
: Cause ________
Post Operative Tracheostomy : Yes / No
: Cause ________
Done On Day _____
POST OPERATIVE COMPLICATIONS
Pneumonia : aspiration / VAP / _________
Pleural Effussion :
ARDS :
Other Pulmonary Complications :
Arrythmias :_______________________
Wound Infection / Dehiscence.
Anastomotic Leak :
Vocal Cord palsy :
Reoperation :
Details :
Other Complications :
Final Biopsy Report : pT ___ N ____ M ____
 Well / moderately / poorly differentiated
 Adeno / sauamous   cell  carcinoma
Margins : Proximal free/ involved
  Distal Free / involved
  Visceral Free /Involved
Nodes Thoracic Positive / Negative ______
Abdominal Positive / Negative _______
Post Operative Contrast study : Done On ______________
: Leak  Present / Absent
FOLLOW UP
Details of Chemo / RT and Follow UP
TRACHEOSTOMY
Changed to metal tube on _________ post op day
Decanulated on _________ post op day
Complications related to the tracheostomy
APPENDIX 2
INFORMED CONSENT FORM
PATIENT INFORMATION
Mr. /Mrs.       :
S/D/W/H of:
Has been diagnosed to have   :
And has been planned for an oesophageal resection/bypass.
In addition to the routine surgery a tracheostomy will be done at the end of surgery for 
the patient.
All other aspects of treatment will not differ from what is routinely followed.
A Tracheostomy helps in better airway management in the post operative period. 
However its exact role is not known.
Complications of the tracheostomy are rare and include hemorrhage and accidental 
decanullation.
If you are willing for this, you will be enrolled in this study, provided you meet the 
inclusion criteria.
CONSENT FORM
I understand that my participation in the study is completely voluntary.
I understand that a tracheostomy will be done at  the time of surgery.
I understand that if I need any further information regarding the rights as a participant in 
the study, I may contact the doctor concerned, at the hospital, at any time.
I have been given an opportunity to ask questions and I have had them answered to my 
satisfaction.
I have read and understood the consent form.
I agree to participate in the study.
_______________________________                                      ___________________
PATIENTS NAME AND SIGNATURE                                            DATE
________________________________
                WITNESS
(NAME AND SIGNATURE)
MASTER DATA VARIABLE DESCRIPTION
Sex 1-male
2-female
Diagnosis 1-carcinoma
2-corrosive stricture
3-others
Smoking 0-nil
1-yes
Alcohol 0-nil
1-yes
Diabetes 0-nil
1-yes
Hypertension 0-nil
1-yes
Chemo/RT 0-nil
1-yes
Type of Surgery 1-Transhiatal
2-Transthoracic
3-Thorascopic assisted
4-Substernal colon pullthrough
Epidural 0-nil
1-yes
One lung ventilation 0-nil
1-yes
Tracheostomy 0-nil
1-yes
2-delayed
Pulmonary complications 0-Nil
1-Pneumonia
2-ARDS
3-Pneumothorax
4-Pleural Effusion
5-Chylothorax
Leak 0-nil
1-yes
Death 0-nil
1-yes
Conduit used 1-Stomach
2-colon
